Picture of BioInvent International AB logo

BINV BioInvent International AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-101-123-138-75.5-278
Depreciation
Non-Cash Items0.3160.2270.379-0.0411.14
Other Non-Cash Items
Changes in Working Capital21.6-23.40.430.88916.8
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-75.9-141-125-62.6-246
Capital Expenditures-16.5-3.85-3.84-6.7-13.3
Purchase of Fixed Assets
Other Investing Cash Flow Items-454
Purchase of Investments
Cash from Investing Activities-16.5-3.85-3.84-6.7-468
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities080.3214645895
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-92.4-64.985.1575181

Or unlock with your email

Or unlock with your email